Stocks · News reference
Veritone Lowers FY2026 Sales Guidance from $130.000M-$145.000M to $100.000M-$115.000M vs $135.032M Est
Veritone (NASDAQ:VERI) lowers FY2026 sales outlook from $130.000 million-$145.000 million to $100.000 million-$115.000 million vs $135.032 million estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 8:06 PM
- Checked
- Aug 13, 2026, 8:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
Top analysts changed outlook on top names. Mizuho raised price target for AIT from $355 to $400. See how analysts view AIT, ETON, PLGO, BRZE, VERI, POWL, AMAT, and YETI.
Read original at benzingaNeedham Maintains Buy on Veritone, Lowers Price Target to $5
Needham analyst Joshua Reilly maintains Veritone (NASDAQ:VERI) with a Buy and lowers the price target from $10 to $5.
Read original at benzingaWhy Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
Read original at benzinga